{"id":"https://openalex.org/W2474777404","doi":null,"title":"[Cytochrome P-450 3A4--the most important arena for drug interactions in the body].","display_name":"[Cytochrome P-450 3A4--the most important arena for drug interactions in the body].","alternate_titles":[],"publication_year":2008,"publication_date":"2008-12-18","ids":{"openalex":"https://openalex.org/W2474777404","mag":"2474777404","pmid":"https://pubmed.ncbi.nlm.nih.gov/19092951"},"language":"no","primary_location":{"id":"mag:2981120151","doi":null,"is_oa":false,"landing_page_url":"https://tidsskriftet.no/2008/12/oversiktsartikkel/cytokrom-p-450-3a4-kroppens-viktigste-arena-legemiddelinteraksjoner","pdf_url":null,"source":{"id":"https://openalex.org/S107880978","display_name":"Tidsskrift for Den Norske Laegeforening","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314069","host_organization_name":"Norwegian Medical Association","host_organization_lineage":["https://openalex.org/P4310314069"],"host_organization_lineage_names":["Norwegian Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Tidsskrift for Den Norske Laegeforening","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2474777404"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031025442","display_name":"Olav Spigset","orcid":"https://orcid.org/0000-0001-7902-9014","observed_orcids":["https://orcid.org/0000-0001-7902-9014"]},"institutions":[{"id":"https://openalex.org/I204778367","display_name":"Norwegian University of Science and Technology","ror":"https://ror.org/05xg72x27","country_code":"NO","type":"education","lineage":["https://openalex.org/I204778367"]},{"id":"https://openalex.org/I4210104358","display_name":"St Olav's University Hospital","ror":"https://ror.org/01a4hbq44","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210104358"]}],"countries":["NO"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olav Spigset","raw_affiliation_strings":["Avdeling for klinisk farmakologi St. Olavs Hospital 7006 Trondheim og Institutt for laboratoriemedisin, barne- og kvinnesykdommer Norges teknisk-naturvitenskapelige universitet. olav.spigset@legemidler.no"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avdeling for klinisk farmakologi St. Olavs Hospital 7006 Trondheim og Institutt for laboratoriemedisin, barne- og kvinnesykdommer Norges teknisk-naturvitenskapelige universitet. olav.spigset@legemidler.no","institution_ids":["https://openalex.org/I204778367","https://openalex.org/I4210104358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043781386","display_name":"Espen Molden","orcid":"https://orcid.org/0000-0001-6190-2751","observed_orcids":["https://orcid.org/0000-0001-6190-2751"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Espen Molden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1899,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.73935484,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"128","issue":"24","first_page":"2832","last_page":"2835"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibitors","display_name":"cytochrome P450 inhibitors","score":0.7829999923706055},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.9039999842643738},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6230000257492065},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9919999837875366},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.9110000133514404},{"id":"https://openalex.org/keywords/patient-monitoring","display_name":"patient monitoring","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.961355447769165},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7594256401062012},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.6850970387458801},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.6211276054382324},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5963270664215088},{"id":"https://openalex.org/C2225953","wikidata":"https://www.wikidata.org/wiki/Q1661899","display_name":"Inducer","level":3,"score":0.5309944152832031},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.483053982257843},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.4272286891937256},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.41920557618141174},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.41414710879325867},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3067997992038727},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22247254848480225},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002317","descriptor_name":"Cardiovascular Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002317","descriptor_name":"Cardiovascular Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002317","descriptor_name":"Cardiovascular Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"mag:2981120151","doi":null,"is_oa":false,"landing_page_url":"https://tidsskriftet.no/2008/12/oversiktsartikkel/cytokrom-p-450-3a4-kroppens-viktigste-arena-legemiddelinteraksjoner","pdf_url":null,"source":{"id":"https://openalex.org/S107880978","display_name":"Tidsskrift for Den Norske Laegeforening","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310314069","host_organization_name":"Norwegian Medical Association","host_organization_lineage":["https://openalex.org/P4310314069"],"host_organization_lineage_names":["Norwegian Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Tidsskrift for Den Norske Laegeforening","raw_type":null},{"id":"pmid:19092951","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19092951","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","raw_type":"Journal Article"},{"id":"mag:2474777404","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19092951","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2809923612","https://openalex.org/W4385698908","https://openalex.org/W1994904603","https://openalex.org/W2356848277","https://openalex.org/W1758640550","https://openalex.org/W2320771407","https://openalex.org/W2021294637","https://openalex.org/W7100863407","https://openalex.org/W2041000829","https://openalex.org/W1980446817"],"abstract_inverted_index":{"BACKGROUND:":[0],"Drug":[1],"metabolism":[2,94],"is":[3,177],"often":[4],"dependent":[5,89],"on":[6,38,66,90],"the":[7,47,59,97,101,130,134],"cytochrome":[8],"P-450":[9],"enzyme":[10,32],"CYP3A4.":[11],"Some":[12],"drugs":[13],"are":[14,21,27],"powerful":[15,82],"inhibitors":[16],"of":[17,58,77,84,100,133,142],"CYP3A4,":[18],"whereas":[19],"others":[20],"inducers.":[22],"Thus,":[23],"numerous":[24],"drug":[25,44,79,88,111,154],"interactions":[26,45,63],"caused":[28],"by":[29],"altered":[30],"CYP3A4":[31,62,85,91],"activity.":[33],"MATERIAL":[34],"AND":[35],"METHOD:":[36],"Based":[37],"our":[39],"own":[40],"continuous":[41],"work":[42],"with":[43,109,122,182],"during":[46],"last":[48],"10":[49,106,140],"-":[50,139],"15":[51],"years,":[52],"we":[53],"here":[54],"present":[55],"an":[56,123,175],"overview":[57],"most":[60],"important":[61],"and":[64,86,113],"suggestions":[65],"how":[67],"to":[68,107,136,147,178],"handle":[69],"them":[70],"in":[71,129,161,172],"clinical":[72,184],"practice.":[73],"RESULTS:":[74],"The":[75],"combination":[76,121],"a":[78,81,87,117,120,127],"being":[80],"inhibitor":[83],"for":[92],"its":[93,143],"may":[95,125],"increase":[96],"plasma":[98,131,163,173],"levels":[99,164,174],"substrate":[102,135,162],"as":[103,105,116,165],"much":[104],"20-fold,":[108],"adverse":[110],"reactions":[112],"toxic":[114],"effects":[115],"result.":[118],"Correspondingly,":[119],"inducer":[124],"cause":[126,157],"decrease":[128],"level":[132],"only":[137],"5":[138],"%":[141],"original":[144],"concentration,":[145],"leading":[146],"therapeutic":[148],"failure.":[149],"INTERPRETATION:":[150],"One":[151],"should":[152],"avoid":[153],"combinations":[155],"that":[156],"such":[158],"profound":[159],"changes":[160,171],"those":[166],"described":[167],"above.":[168],"With":[169],"smaller":[170],"alternative":[176],"combine":[179],"dose":[180],"adjustments":[181],"frequent":[183],"controls.":[185]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2474777404","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-07-22T00:00:00"}
